PG

Philip D. Gregory

ST Sangamo Therapeutics: 8 patents #2 of 45Top 5%
OS Ospedale San Raffaele S.R.L.: 3 patents #2 of 26Top 8%
FT Fondazione Telethon: 1 patents #2 of 13Top 20%
University Of Texas System: 1 patents #80 of 560Top 15%
🗺 California: #1,514 of 60,411 inventorsTop 3%
Overall (2018): #10,073 of 503,207Top 3%
8
Patents 2018

Issued Patents 2018

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10155011 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases Maria Chiara Bonini, Pietro Genovese, Michael C. Holmes, Luigi Naldini, David Paschon +2 more 2018-12-18
10117899 Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells Pietro Genovese, Michael C. Holmes, Angelo Leone Lombardo, Luigi Naldini 2018-11-06
10072062 Methods and compositions for modification of a HLA locus Trevor Collingwood, Laurence J.N. COOPER, Michael C. Holmes, Jeffrey C. Miller, Edward J. Rebar +2 more 2018-09-11
10046028 Methods and compositions for modulating PD1 Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik +1 more 2018-08-14
9963715 Methods and compositions for treatment of a genetic condition Gregory J. Cost, Dmitry Guschin, Michael C. Holmes, Jeffrey C. Miller, David Paschon +4 more 2018-05-08
9943565 Methods and compositions for treating trinucleotide repeat disorders Edward J. Rebar, H. Steve Zhang 2018-04-17
9937207 Targeted disruption of T cell receptor genes using talens Michael C. Holmes, David Paschon, Lei Zhang, Maria Chiara Bonini, Pietro Genovese +3 more 2018-04-10
9914940 Targeted integration into the PPP1R12C locus Russell DeKelver, David Paschon, Phillip Tam, Fyodor Urnov 2018-03-13